NMS Capital has exited its investment in Flourish Research, a US-based clinical trial organization, through a sale to Genstar Capital. No financial terms were disclosed.

Original research ranges from new concepts in human biology and disease pathogenesis to new therapeutic modalities and drug development, to all phases of clinical work, as well as innovative ...

For instance, AI algorithms can rapidly screen millions of compounds, significantly speeding up the initial phases of drug ..

BioDuro-Sundia opens new kilogram laboratory at Shanghai to speed development from discovery to preclincal and clinical ...

"We identified two main phases in AD by arranging donors along ... with no symptoms to advanced dementia cases. "By studying research subjects across the spectrum of AD, including those in the ...

The rising prevalence of urticaria is fueling market growth, with increased allergic responses and lifestyle shifts playing key roles. Advances in biologic treatments and a strong development pipeline ...

LifeSci Capital analyst Anshul Dhankher maintained a Buy rating on Perspective Therapeutics (CATX – Research Report ... The company has shown consistent execution in its clinical programs, ...

Objectives Secondary prevention of rheumatoid arthritis (RA) is generally considered potentially impactful because the entire ...

Innovative products, such as those being developed by DELFI, will aid in the efficient progress of those medicines through the clinic," said Susan Macdonald, PhD, SVP Nonclinical Development & ...

See what moon phase it is tonight and find out when you can see the rest of the moon phases for 2024. Today, Nov. 12, 2024, the moon is 11 days old and is in the Waxing Gibbous phase of its lunar ...

Alzheimer’s Disease Could Be Slowed By Boosting A Certain Protein In The Brain, Researchers Say "We identified two main phases in AD ... Suggests "By studying research subjects across the ...